Tronox Holdings
NYSE: TROX
$5.95 ▼ -0.29  (-4.73%)
At close: Jul 27, 2026 · 2:55 PM UTC
Financial Ratios
Market Cap943.01 Mn
P/E-2.02
P/S0.32
Div. Yield0.06
ROIC (Qtr)-0.01
Total Debt (Qtr)3.16 Bn
Revenue Growth (1y) (Qtr)2.98
Add ratio to table…

About

Tronox is the world’s leading vertically integrated manufacturer of titanium dioxide pigment. The company extracts titanium bearing mineral sands from operations in South Africa and Australia, then beneficiates and smelts the material to produce feedstock such as titanium slag and synthetic rutile. These feedstocks are processed into TiO2 pigment at seven plants located in the United States, Australia, Brazil, the United Kingdom, France and Saudi Arabia. In addition to…

Read more ↓
Sector: Basic Materials Industry: Chemicals CIK: 0001530804

Investment Thesis

▲ Bull case
  • Tronox’s chloride-based production model provides a structural competitive advantage over sulfate-reliant Chinese competitors, as more than 90% of its TiO2 capacity utilizes chloride technology, which is insulated from the sulfur supply crisis that has driven Chinese sulfuric acid prices up nearly 300% since end-2024. This cost disparity is forcing Tier 2 and Tier 3 Chinese producers to curtail or idle capacity due to sulfur unavailability, not just price, creating a tightening global supply dynamic that Tronox is uniquely positioned to exploit. With antidumping investigations now underway in the U.K. and Australia — building on existing measures in Europe, Brazil, and Saudi Arabia — Tronox is benefiting from redirected trade flows and improved pricing power in protected markets. Management noted that these structural trade shifts, combined with their global footprint and reliable supply, allowed them to serve customers effectively while capturing upside as supply chains rebalanced, a trend that remains underappreciated by the market focused on near-term volatility.
  • Tronox’s working capital transformation is generating significant latent cash flow potential, with $75 million in inventory reduction achieved in Q1 alone and a guided full-year working capital inflow of well over $100 million. This is not merely a seasonal timing benefit but the result of deliberate, sustained actions to operate for cash, including lowered operating rates and strategic idling of underperforming assets in South Africa and Australia during the downturn. The company’s ability to convert inventory into cash — evidenced by the upsizing of its AR securitization facility by $45 million total in Q1 and early Q2 — demonstrates operational discipline that is improving its cash conversion cycle structurally. With net debt of $3.2 billion and no significant maturities until 2029, combined with 74% of interest rates fixed through 2028, Tronox has a resilient balance sheet that can withstand near-term headwinds while positioning itself to deleverage aggressively as free cash flow converts to earnings in the second half of 2026.
  • Tronox’s rare earths initiative, advanced by the Australian government’s federal major project status award earlier in the week, represents a de-risked, high-potential growth platform that leverages its existing mining footprint and hydrometallurgical expertise. While management emphasized disciplined capital allocation and avoided overpromising, the project’s progression toward a definitive feasibility study — coupled with active engagement from strategic partners, potential customers, and funding sources — suggests a viable path to downstream production of separated rare earth oxides. This vertical integration into a strategically critical mineral sector, pursued without material incremental leverage, offers a long-term value driver that the market is currently overlooking amid focus on TiO2 cyclicality, especially as global demand for rare earths rises amid clean energy and defense supply chain initiatives.
▼ Bear case
  • Tronox’s pricing momentum remains fragile and overly dependent on temporary geopolitical disruptions, particularly the Middle East conflict, which has disrupted sulfur supply and artificially inflated costs for Chinese sulfate producers. While management highlighted surcharges in Brazil to offset sulfur-driven cost inflation, they acknowledged that these are lagging indicators — with the Bahia facility surcharge only taking effect May 1 — meaning Q2 results will not fully reflect the benefit, and any resolution in the conflict could rapidly erase the cost advantage Tronox currently enjoys. The company’s ability to pass on costs via surcharges is constrained by margin stability agreements in the Americas, which delay pricing implementation, and there is no evidence that Chinese producers will exit the market permanently; instead, they may simply delay exports until sulfur availability improves, leaving Tronox exposed to a sudden influx of low-cost supply once conditions normalize.
  • Tronox’s volume growth is increasingly reliant on inventory drawdown rather than organic demand strength, with Q1 TiO2 volumes reaching their highest level since 2022 not due to new customer acquisition but due to the deliberate release of higher-cost inventory accumulated during prior production cuts. Management admitted that selling this high-cost inventory in Q1 had a negative earnings impact, and the shift to selling lower-cost Q1-produced inventory in Q2 is expected to provide only a temporary uplift. Once this inventory cycle completes, sustained volume growth will depend on genuine demand recovery — which remains uncertain given the company’s acknowledgment that Asian Pacific volumes were only “more resilient than expected” due to temporary duty stays in India, and that zircon volume moderation in Q2 is directly tied to depleted consignment inventory, not stronger end-market demand.
  • Tronox’s capital allocation priorities, while focused on cash generation, are underpinned by continued investment in non-core initiatives like rare earths that lack near-term monetization clarity and may divert focus from core TiO2 profitability. Although management stressed disciplined capital management and avoiding incremental leverage, the rare earths project remains in the feasibility stage with no defined timeline for commercial production, and the award of federal major project status in Australia, while positive, does not guarantee funding or offtake agreements. Simultaneously, the company continues to incur $67 million in quarterly capital expenditures primarily for maintenance and safety — a level that, if sustained, implies $260 million annually — which strains free cash flow conversion despite working capital gains. With net debt still at $3.2 billion and adjusted EBITDA down 45% year-over-year in Q1, the path to meaningfully reducing leverage depends on optimistic assumptions about sustained pricing power and inventory-driven cash flow that may not persist beyond the current geopolitical window.

Geographical Breakdown of Revenue (2025)

Product and Service Breakdown of Revenue (2025)

Peer Comparison

Companies in the Chemicals
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 CE Celanese Corp 4.87 Bn-286.350.5112.55 Bn
2 MEOH Methanex Corp 4.17 Bn-77.631.142.71 Bn
3 OLN OLIN Corp 2.49 Bn-13.460.373.00 Bn
4 BAK Braskem Sa 1.94 Bn-8.450.159.61 Bn
5 REX REX AMERICAN RESOURCES Corp 1.46 Bn17.212.25-
6 GPRE Green Plains Inc. 1.14 Bn86.590.590.46 Bn
7 TROX Tronox Holdings plc 0.94 Bn-2.020.323.16 Bn
8 LXU Lsb Industries, Inc. 0.83 Bn17.701.290.45 Bn